Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|January 17, 2018
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer RiskPer E Lønning, Elisabet O Berge, Merete Bjørnslett, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
Cancer Research Communications|November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerMaj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.
Nature Reviews. Clinical Oncology|February 28, 2018
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Allison Jones, Iona Evans, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial CancerTarjei S Hveem, Tormund S Njølstad, Birgitte Nielsen, et al.
The Lancet. Oncology|November 23, 2015
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trialAndreas du Bois, Gunnar Kristensen, Isabelle Ray-Coquard, et al.
Acta Oncologica (Stockholm, Sweden)|May 23, 2024
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary resultsKatarina Puco, Gro Live Fagereng, Sigmund Brabrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2022
A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control SetsChiara Herzog, Fátima Marín, Allison Jones, et al.
Therapeutic Advances in Medical Oncology|October 14, 2025
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxelMatthew A Powell, Line Bjørge, Lyndsay Willmott, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 27, 2023
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysisTaymaa May, Marcus Bernardini, Stephanie Lheureux, et al.
Pageof 11